Gene · 1399
Papers2,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The p130Cas-Crk/CrkL Axis: A Therapeutic Target for Invasive Cancers Unveiled by Collaboration Among p130Cas, Crk, and CrkL. | Int J Mol Sci | 2025 | 40362257 | PubTator, text mining | PubMed |
| tRF-5028c disrupts trophoblast function in recurrent spontaneous abortion by inhibiting CRKL-mediated Rap1 signaling pathway. | Cell Mol Biol Lett | 2025 | 40045194 | PubTator, text mining | PubMed |
| CRKL silencing inhibits melanoma growth and enhances its chemotherapy sensitivity through the PI3K/AKT and NLRP3/GSDMD pathways. | Biochem Pharmacol | 2025 | 40024349 | PubTator, text mining | PubMed |
| 22q11.21 Deletions: A Review on the Interval Mediated by Low-Copy Repeats C and D. | Genes (Basel) | 2025 | 39858619 | PubTator, text mining | PubMed |
| CRKL Gene Deletion in Familial Zinner (OSVIRA) and OHVIRA Syndromes. | Pediatrics | 2025 | 39729079 | PubTator, text mining | PubMed |
| SLAMF7 (CD319) on activated CD8+ T cells transduces environmental cues to initiate cytotoxic effector cell responses. | Cell Death Differ | 2025 | 39390117 | PubTator, text mining | PubMed |
| scHiClassifier: a deep learning framework for cell type prediction by fusing multiple feature sets from single-cell Hi-C data. | Brief Bioinform | 2024 | 39831891 | PubTator, text mining | PubMed |
| Serum proteome profiling of plateau acclimatization in men using Olink proteomics approach. | Physiol Rep | 2024 | 39725655 | PubTator, text mining | PubMed |
| Large-scale characterization of drug mechanism of action using proteome-wide thermal shift assays. | Elife | 2024 | 39526730 | PubTator, text mining | PubMed |
| Abl kinases regulate FGF signaling independent of Crk phosphorylation to prevent Peters anomaly. | bioRxiv | 2024 | 39484567 | PubTator, text mining | PubMed |
| Differential expression of cardiometabolic and inflammation markers and signaling pathways between overweight/obese Qatari adults with high and low plasma salivary α-amylase activity. | Front Endocrinol (Lausanne) | 2024 | 39411310 | PubTator, text mining | PubMed |
| Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer. | NPJ Precis Oncol | 2024 | 39349771 | PubTator, text mining | PubMed |
| CRKL Enhances YAP Signaling through Binding and JNK/JUN Pathway Activation in Liver Cancer. | Int J Mol Sci | 2024 | 39126118 | PubTator, text mining | PubMed |
| 3D genomic analysis reveals novel enhancer-hijacking caused by complex structural alterations that drive oncogene overexpression. | Nat Commun | 2024 | 39033128 | PubTator, text mining | PubMed |
| Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling. | Int J Cancer | 2024 | 39001563 | PubTator, text mining | PubMed |
| Use of phosphotyrosine-containing peptides to target SH2 domains: Antagonist peptides of the Crk/CrkL-p130Cas axis. | Methods Enzymol | 2024 | 38886037 | PubTator, text mining | PubMed |
| An integrated classification of tumor suppressor IKZF1 inactivation and oncogenic activation in Philadelphia chromosome-like acute lymphoblastic leukemia. | Hemasphere | 2024 | 38774654 | PubTator, text mining | PubMed |
| A reduced proteomic signature in critically ill Covid-19 patients determined with plasma antibody micro-array and machine learning. | Clin Proteomics | 2024 | 38760690 | PubTator, text mining | PubMed |
| Risk of meningomyelocele mediated by the common 22q11.2 deletion. | Science | 2024 | 38696583 | PubTator, text mining | PubMed |
| CRKL but not CRKII contributes to hemin-induced erythroid differentiation of CML. | J Cell Mol Med | 2024 | 38683131 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1399/papers?page=3